These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7140561)

  • 1. [Preventive anticoagulant therapy of mitral valve defects?].
    Funfack W; Schüren KP
    Dtsch Med Wochenschr; 1982 Nov; 107(46):1771-5. PubMed ID: 7140561
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of thromboembolism in auricular fibrillation in mitral valve disease].
    Kałunzna J; Judkiewicz L; Pracka H; Moll J; Bolińska H; Zasłonka J
    Pol Tyg Lek; 1981 Aug; 36(34):1293-6. PubMed ID: 7335512
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of anticoagulant therapy in patients with mitral defects].
    Mihajlović V
    Med Glas; 1966 Sep; 20(9):343-4. PubMed ID: 5975883
    [No Abstract]   [Full Text] [Related]  

  • 4. [Positive effect of nitroglycerin in patients with combined mitral valve defects].
    Górski W; Zochowski RJ
    Kardiol Pol; 1988; 31(3):154-64. PubMed ID: 3146667
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitral valve disease, systemic embolism and anticoagulants.
    Fleming HA; Bailey SM
    Postgrad Med J; 1971 Sep; 47(551):599-604. PubMed ID: 5098918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the problem of the method of prolonged use of cardiac glycosides in patients with mitral defects and chronic circulatory insufficiency].
    Kats GL
    Sov Med; 1967 Apr; 30(4):79-83. PubMed ID: 5608582
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic effects of trinitroglycerin in aortic and mitral valve disease.
    Kasliwal RS; Manchanda SC; Bhatia ML; Wasir HS
    Indian Heart J; 1980; 32(1):30-6. PubMed ID: 6769780
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pulmonary thromboembolism in patients with mitral disease].
    Mihăilescu VV; Cherulescu N; Pîrlog C; Draghici D; Bunghez G; Efraim M; Dosios L
    Med Interna (Bucur); 1967 Apr; 19(4):439-44. PubMed ID: 6052154
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the hemodynamic effects of nitroglycerin in mitral stenosis and insufficiency. A guide to their management].
    González Juanatey JR; Amaro A; Rubio J; Gil M
    Rev Esp Cardiol; 1985; 38(2):108-12. PubMed ID: 3923577
    [No Abstract]   [Full Text] [Related]  

  • 10. [Necessity of permanent anticoagulant therapy for isolated mitral valve replacement with bioprosthetic heart valve to prevent the postoperative thromboembolic complications].
    Yao H; Miyamoto T; Yamashita K; Mukai M; Wada T; Yamamura M; Nakagawa T; Ryomoto M
    Kyobu Geka; 2000 Apr; 53(4):337-40. PubMed ID: 10770064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Streptokinase therapy in mitral valve disease].
    Poliwoda H
    Dtsch Med Wochenschr; 1970 Dec; 95(52):2625. PubMed ID: 5487518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Simultaneous use of 2 glycosides in various combinations in patients with mitral defects and circulatory insufficiency].
    Kats GL
    Ter Arkh; 1969 Jun; 41(6):84-8. PubMed ID: 5364565
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
    J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial.
    Pérez-Gómez F; Salvador A; Zumalde J; Iriarte JA; Berjón J; Alegría E; Almería C; Bover R; Herrera D; Fernández C
    Eur Heart J; 2006 Apr; 27(8):960-7. PubMed ID: 16330464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic modifications induced by beta and alpha hypertensin].
    Fancini P; Colombi M; Ladelli G
    Minerva Cardioangiol; 1966 Mar; 14(3):153-62. PubMed ID: 4287098
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticoagulant therapy].
    Sato M
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():70-4. PubMed ID: 17469536
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic effects of lidocaine.
    Cullhed I
    Isr J Med Sci; 1969; 5(4):750-3. PubMed ID: 5820510
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anticoagulant therapy for the mitral disease with special reference to preoperative treatment].
    Watanabe T; Hara T; Nakamichi S; Konishi T; Inaba S
    Kyobu Geka; 1971 Jun; 24(6):381-7. PubMed ID: 5104512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for surgery in mitral valve stenosis].
    Korolev BA; Karpov VV
    Vopr Revm; 1982; (1):3-6. PubMed ID: 7090312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.